Canada markets open in 7 hours 51 minutes

Adverum Biotechnologies, Inc. (ADVM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
9.72+0.19 (+1.99%)
At close: 04:00PM EDT
9.72 0.00 (0.00%)
After hours: 04:09PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 201.53M
Enterprise Value 180.04M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)27.19
Price/Book (mrq)2.41
Enterprise Value/Revenue 50.01
Enterprise Value/EBITDA -1.52

Trading Information

Stock Price History

Beta (5Y Monthly) 0.79
52-Week Change 326.23%
S&P500 52-Week Change 323.10%
52 Week High 329.70
52 Week Low 37.40
50-Day Moving Average 315.09
200-Day Moving Average 313.63

Share Statistics

Avg Vol (3 month) 3330.9k
Avg Vol (10 day) 3394.05k
Shares Outstanding 520.75M
Implied Shares Outstanding 620.75M
Float 811.72M
% Held by Insiders 10.91%
% Held by Institutions 183.51%
Shares Short (Apr 15, 2024) 41.13M
Short Ratio (Apr 15, 2024) 43.81
Short % of Float (Apr 15, 2024) 45.67%
Short % of Shares Outstanding (Apr 15, 2024) 45.45%
Shares Short (prior month Mar 15, 2024) 4648.48k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Mar 21, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,437.97%

Management Effectiveness

Return on Assets (ttm)-32.14%
Return on Equity (ttm)-88.43%

Income Statement

Revenue (ttm)3.6M
Revenue Per Share (ttm)0.36
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -118.12M
Net Income Avi to Common (ttm)-117.17M
Diluted EPS (ttm)-11.60
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)96.53M
Total Cash Per Share (mrq)4.65
Total Debt (mrq)75.04M
Total Debt/Equity (mrq)89.90%
Current Ratio (mrq)4.12
Book Value Per Share (mrq)8.23

Cash Flow Statement

Operating Cash Flow (ttm)-90.9M
Levered Free Cash Flow (ttm)-60.69M